Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blind

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Analytical Biochemistry|July 1, 1993
Development and validation of an assay to measure bioactivity of human calcitonin in vitro using T47D cell membranesE Blind, F Raue, P Kienle, et al.
Deutsche Medizinische Wochenschrift (1946)|March 12, 1993
[Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia]E Blind, F Raue, T Meinel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1995
Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat modelT Schilling, E Blind, R Baier, et al.
The Clinical Investigator|January 1, 1993
Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assayE Blind, F Raue, T Meinel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 28, 2024
A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapiesJill E Blind, Sumit Ghosh, Taylor D Niese, et al.
Pediatric Neurology|June 27, 2025
Same-Day Approach for Combined Intravitreal and Intracerebroventricular Enzyme Replacement Therapy to Prevent Retinal Disease Progression in Children With Neuronal Ceroid Lipofuscinosis Type 2David L Rogers, Jill E Blind, Troy Kienzle, et al.
Journal of Immunoassay|January 1, 1992
Characterization of antibodies against human N-terminal parathyroid hormone by epitope mappingJ Tampe, P Broszio, H E Manneck, et al.
Deutsche Medizinische Wochenschrift (1946)|July 10, 1987
[Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol]S H Scharla, H W Minne, P Sattar, et al.
Bone|October 12, 2001
A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannomaM R John, H Wickert, K Zaar, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 8, 2025
ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health SystemsJoseph T DiPiro, Rick Couldry, Anna Legreid Dopp, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Analytical Biochemistry|July 1, 1993
Development and validation of an assay to measure bioactivity of human calcitonin in vitro using T47D cell membranesE Blind, F Raue, P Kienle, et al.
Deutsche Medizinische Wochenschrift (1946)|March 12, 1993
[Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia]E Blind, F Raue, T Meinel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1995
Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat modelT Schilling, E Blind, R Baier, et al.
The Clinical Investigator|January 1, 1993
Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assayE Blind, F Raue, T Meinel, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 28, 2024
A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapiesJill E Blind, Sumit Ghosh, Taylor D Niese, et al.
Pediatric Neurology|June 27, 2025
Same-Day Approach for Combined Intravitreal and Intracerebroventricular Enzyme Replacement Therapy to Prevent Retinal Disease Progression in Children With Neuronal Ceroid Lipofuscinosis Type 2David L Rogers, Jill E Blind, Troy Kienzle, et al.
Journal of Immunoassay|January 1, 1992
Characterization of antibodies against human N-terminal parathyroid hormone by epitope mappingJ Tampe, P Broszio, H E Manneck, et al.
Deutsche Medizinische Wochenschrift (1946)|July 10, 1987
[Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol]S H Scharla, H W Minne, P Sattar, et al.
Bone|October 12, 2001
A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannomaM R John, H Wickert, K Zaar, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 8, 2025
ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health SystemsJoseph T DiPiro, Rick Couldry, Anna Legreid Dopp, et al.
Pageof 5